GlassScriptPhysician profile
Walter D Kolmodin
NPI 1265427645
$1,809.72
in general payments reported to CMS, 2019-2025
11 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $176 · 2021: $279 · 2022: $319 · 2023: $348 · 2024: $116 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $647.78 | 2019-2023 | Puraply |
| Stryker Corporation | $340.01 | 2021-2025 | Actishield, Viaflow, Citrefix |
| Kerecis Limited | $324.32 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $130.10 | 2020-2025 | Collagenase Santyl |
| Mimedx Group, INC. | $114.30 | 2025 | Epi Line Products All Epi |
| Wright Medical Technology, INC. | $100.11 | 2019-2020 | |
| Nevro Corp. | $39.94 | 2022-2024 | Senza |
| Tactile Systems Technology INC | $34.37 | 2025 | Nimbl, Flexitouch Plus |
| Convatec INC. | $32.39 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.36 | 2025 | |
| Kci USA, INC. | $15.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Kolmodin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.